Trastuzumab Emtansine Enhances Long-Term Survival Rates in HER2-Positive Breast Cancer Patients
In recent groundbreaking research, the significance of trastuzumab emtansine (T-DM1) has taken center stage in the battle against high-risk HER2-positive breast cancer. According to the...